MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy
Malignant glioblastoma (GBM, glioma) is the most common and aggressive primary adult brain tumor. The prognosis of GBM patients remains poor, despite surgery, radiation and chemotherapy. The major obstacles for successful remedy are invasiveness and therapy resistance of GBM cells. Invasive glioma c...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Non-Coding RNA |
Subjects: | |
Online Access: | http://www.mdpi.com/2311-553X/5/1/25 |
id |
doaj-8214984655a749fb9d0527337e2de589 |
---|---|
record_format |
Article |
spelling |
doaj-8214984655a749fb9d0527337e2de5892020-11-25T02:44:54ZengMDPI AGNon-Coding RNA2311-553X2019-03-01512510.3390/ncrna5010025ncrna5010025MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional TherapyDaisuke Ogawa0Khairul Ansari1Michal O. Nowicki2Elżbieta Salińska3Agnieszka Bronisz4Jakub Godlewski5Department of Neurosurgery, Harvey Cushing Neuro-oncology Laboratories, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USADepartment of Neurosurgery, Harvey Cushing Neuro-oncology Laboratories, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USADepartment of Neurosurgery, Harvey Cushing Neuro-oncology Laboratories, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USADepartment of Neurochemistry, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106 Warsaw, PolandDepartment of Neurosurgery, Harvey Cushing Neuro-oncology Laboratories, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USADepartment of Neurosurgery, Harvey Cushing Neuro-oncology Laboratories, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USAMalignant glioblastoma (GBM, glioma) is the most common and aggressive primary adult brain tumor. The prognosis of GBM patients remains poor, despite surgery, radiation and chemotherapy. The major obstacles for successful remedy are invasiveness and therapy resistance of GBM cells. Invasive glioma cells leave primary tumor core and infiltrate surrounding normal brain leading to inevitable recurrence, even after surgical resection, radiation and chemotherapy. Therapy resistance allowing for selection of more aggressive and resistant sub-populations including GBM stem-like cells (GSCs) upon treatment is another serious impediment to successful treatment. Through their regulation of multiple genes, microRNAs can orchestrate complex programs of gene expression and act as master regulators of cellular processes. MicroRNA-based therapeutics could thus impact broad cellular programs, leading to inhibition of invasion and sensitization to radio/chemotherapy. Our data show that miR-451 attenuates glioma cell migration in vitro and invasion in vivo. In addition, we have found that miR-451 sensitizes glioma cells to conventional chemo- and radio-therapy. Our data also show that miR-451 is regulated in vivo by AMPK pathway and that AMPK/miR-451 loop has the ability to switch between proliferative and migratory pattern of glioma cells behavior. We therefore postulate that AMPK/miR-451 negative reciprocal feedback loop allows GBM cells/GSCs to adapt to tumor “ecosystem” by metabolic and behavioral flexibility, and that disruption of such a loop reduces invasiveness and diminishes therapy resistance.http://www.mdpi.com/2311-553X/5/1/25glioblastomamicroRNAAMPKinvasivenesstherapy resistance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daisuke Ogawa Khairul Ansari Michal O. Nowicki Elżbieta Salińska Agnieszka Bronisz Jakub Godlewski |
spellingShingle |
Daisuke Ogawa Khairul Ansari Michal O. Nowicki Elżbieta Salińska Agnieszka Bronisz Jakub Godlewski MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy Non-Coding RNA glioblastoma microRNA AMPK invasiveness therapy resistance |
author_facet |
Daisuke Ogawa Khairul Ansari Michal O. Nowicki Elżbieta Salińska Agnieszka Bronisz Jakub Godlewski |
author_sort |
Daisuke Ogawa |
title |
MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy |
title_short |
MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy |
title_full |
MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy |
title_fullStr |
MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy |
title_full_unstemmed |
MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy |
title_sort |
microrna-451 inhibits migration of glioblastoma while making it more susceptible to conventional therapy |
publisher |
MDPI AG |
series |
Non-Coding RNA |
issn |
2311-553X |
publishDate |
2019-03-01 |
description |
Malignant glioblastoma (GBM, glioma) is the most common and aggressive primary adult brain tumor. The prognosis of GBM patients remains poor, despite surgery, radiation and chemotherapy. The major obstacles for successful remedy are invasiveness and therapy resistance of GBM cells. Invasive glioma cells leave primary tumor core and infiltrate surrounding normal brain leading to inevitable recurrence, even after surgical resection, radiation and chemotherapy. Therapy resistance allowing for selection of more aggressive and resistant sub-populations including GBM stem-like cells (GSCs) upon treatment is another serious impediment to successful treatment. Through their regulation of multiple genes, microRNAs can orchestrate complex programs of gene expression and act as master regulators of cellular processes. MicroRNA-based therapeutics could thus impact broad cellular programs, leading to inhibition of invasion and sensitization to radio/chemotherapy. Our data show that miR-451 attenuates glioma cell migration in vitro and invasion in vivo. In addition, we have found that miR-451 sensitizes glioma cells to conventional chemo- and radio-therapy. Our data also show that miR-451 is regulated in vivo by AMPK pathway and that AMPK/miR-451 loop has the ability to switch between proliferative and migratory pattern of glioma cells behavior. We therefore postulate that AMPK/miR-451 negative reciprocal feedback loop allows GBM cells/GSCs to adapt to tumor “ecosystem” by metabolic and behavioral flexibility, and that disruption of such a loop reduces invasiveness and diminishes therapy resistance. |
topic |
glioblastoma microRNA AMPK invasiveness therapy resistance |
url |
http://www.mdpi.com/2311-553X/5/1/25 |
work_keys_str_mv |
AT daisukeogawa microrna451inhibitsmigrationofglioblastomawhilemakingitmoresusceptibletoconventionaltherapy AT khairulansari microrna451inhibitsmigrationofglioblastomawhilemakingitmoresusceptibletoconventionaltherapy AT michalonowicki microrna451inhibitsmigrationofglioblastomawhilemakingitmoresusceptibletoconventionaltherapy AT elzbietasalinska microrna451inhibitsmigrationofglioblastomawhilemakingitmoresusceptibletoconventionaltherapy AT agnieszkabronisz microrna451inhibitsmigrationofglioblastomawhilemakingitmoresusceptibletoconventionaltherapy AT jakubgodlewski microrna451inhibitsmigrationofglioblastomawhilemakingitmoresusceptibletoconventionaltherapy |
_version_ |
1724765289204154368 |